BRISKPE Doubles Down on Trust with ISO 27001 and SOC 2 Type 2 Certifications
Earning both certifications early signals the company's unwavering commitment to secure infrastructure,…
Ozempic (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
Ozempic® improved maximum walking distance by 13% vs placebo in adults with…
VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA
SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization…
IDfy Completes SOC 2 Type II Attestation, Strengthening Data Security and Operational Excellence
MUMBAI, India, Feb. 28, 2025 /PRNewswire/ -- IDfy, India's leading identity verification…
NetSentries & NSTCyber Achieve SOC 2 Type II Certification
SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ -- NetSentries Technologies, a leader…
Nanoprecise Sci Corp. Renews SOC 2 Type 2 Certification, Reinforcing Commitment to Security Excellence
EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ -- Nanoprecise Sci Corp., a global leader…
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
January 20, 2025 19:00 ET | Source: Disc Medicine Inc WATERTOWN, Mass.,…
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
TraceLink Successfully Completes Industry-Leading Audits: ISO/IEC 27001:2022, ISO/IEC 27017:2015, SOC 2/ISAE 3000 Type II, and CyberVadis
Independent Audits Confirm TraceLink's Compliance with Leading Global Security Standards, Ensuring Customer…
TraceLink Successfully Completes Industry-Leading Audits: ISO/IEC 27001:2022, ISO/IEC 27017:2015, SOC 2/ISAE 3000 Type II, and CyberVadis
Independent Audits Confirm TraceLink's Compliance with Leading Global Security Standards, Ensuring Customer…